Dividend Increases Expected for Abbott Laboratories

Abbott (ABT) is a global, broad-based health care company. Abbott’s primary businesses include pharmaceuticals, with key therapeutic areas including immunology, cardiology and infectious diseases; nutritional products for infants, children and adults with special dietary needs; and medical products, including vascular, laboratory and molecular diagnostics, vision care and diabetes. The company markets its products in more than 130 countries. Abbott reported third quarter sales increased a healthy 11.8% to $8.7 billion, driven by global pharmaceutical sales as well as worldwide vascular products sales. During the third quarter, the company expanded its overseas presence with the acquisition of Piramal Healthcare Solutions, one of the biggest generic pharmaceutical suppliers in India.... Read more

Older articles featuring ABT: